Candel Therapeutics Inc Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation Transcript - Thomson StreetEvents

Candel Therapeutics Inc Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation Transcript

Candel Therapeutics Inc Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation Transcript - Thomson StreetEvents
Candel Therapeutics Inc Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation Transcript
Published Jun 03, 2025
14 pages (7950 words) — Published Jun 03, 2025
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of CADL.OQ corporate analyst meeting

  
Brief Excerpt:

...Operator Good afternoon and welcome to the Candel Therapeutics conference call where the company will be discussing top line results of its Phase 3 prostate cancer clinical trial following the 2025 American Society of Clinical Oncology oral presentation with subsequent Q&A from candle Management and their guests, thought leader physicians. (Operator Instructions) Please be advised that this call is being recorded. You can find the information on the replay of the call and further information related to today's announcement on the Candel Therapeutics website at candeltx.com. At this time, I would like to turn the call over to Ted Jenkins, Vice President, Investor Relations and Business Development at Candel Therapeutics. Mr. Jenkins, please go ahead. Ted Jenkins ...

  
Report Type:

Transcript

Source:
Company:
Candel Therapeutics Inc
Ticker
CADL.OQ
Time
5:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

Candel Therapeutics Inc R&D Event Transcript – 2025-12-05 – US$ 54.00 – Edited Transcript of CADL.OQ corporate analyst meeting</ 5-Dec-25 4:00pm GMT

Candel Therapeutics Inc at Citi Biopharma Back to School Conference Transcript – 2025-09-03 – US$ 54.00 – Edited Transcript of CADL.OQ presentation 3-Sep-25 1:00pm GMT

Candel Therapeutics Inc Annual Shareholders Meeting Transcript – 2025-06-17 – US$ 54.00 – Edited Transcript of CADL.OQ shareholder or annual meeting 17-Jun-25 2:00pm GMT

Candel Therapeutics Inc at Bank of America Global Healthcare Conference Transcript – 2025-05-14 – US$ 54.00 – Edited Transcript of CADL.OQ presentation 14-May-25 11:20pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Candel Therapeutics Inc Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation Transcript" Jun 03, 2025. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Candel-Therapeutics-Inc-Investor-Conference-Call-Featuring-Expert-Clinical-Perspectives-on-CAN-2409-Phase-3-Prostate-Cancer-Data-Following-2025-ASCO-Presentation-T16393386>
  
APA:
Thomson StreetEvents. (2025). Candel Therapeutics Inc Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation Transcript Jun 03, 2025. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Candel-Therapeutics-Inc-Investor-Conference-Call-Featuring-Expert-Clinical-Perspectives-on-CAN-2409-Phase-3-Prostate-Cancer-Data-Following-2025-ASCO-Presentation-T16393386>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.